Israeli ingredients group Gadot Biochemical Industries has acquired an 85% stake in Florida-based US ingredients company Pharmline Holding.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more


Pharmline is a private company that processes and markets ingredients and premixes to the nutraceuticals market in North America. The group posted 2006 revenues of approximately US$37m


“The acquisition of Pharmline is in line with Gadot’s growth strategy — focusing on the nutraceutical and functional food markets,” Jacob Zack, CEO of Gadot, commented. “Pharmline is an important link in the supply chain to these markets and this acquisition will enable Gadot to diversify its products line and to broaden its customer base in North America.”


The deal is expected to be completed by the end of June.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Just Food Excellence Awards - The Benefits of Entering

Gain the recognition you deserve! The Just Food Excellence Awards celebrate innovation, leadership, and impact. By entering, you showcase your achievements, elevate your industry profile, and position yourself among top leaders driving food industry advancements. Don’t miss your chance to stand out—submit your entry today!

Nominate Now